Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?

被引:9
作者
Alsolami, Reem [1 ,2 ]
Knight, Samantha J. L. [1 ,3 ]
Schuh, Anna [1 ]
机构
[1] Univ Oxford, Res Biomed Res Ctr, Oxford Natl Inst Hlth, Oxford, England
[2] King Abdulaziz Univ, Fac Appl Med Sci, Jeddah 21413, Saudi Arabia
[3] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England
基金
英国惠康基金;
关键词
chronic lymphocytic leukemia; genome-wide technologies; massively parallel sequencing; next-generation technology; predictive biomarker; prognostic biomarker; SNP microarray; LRF CLL4 TRIAL; ACUTE MYELOID-LEUKEMIA; DENSITY SNP ARRAYS; TERM-FOLLOW-UP; CLONAL EVOLUTION; COPY-NUMBER; NOTCH1; MUTATIONS; SF3B1; TP53; MUTATION; B-CLL;
D O I
10.2217/PME.13.33
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic lymphocytic leukemia (CLL) is low-grade lymphoma of mature B cells and it is considered to be the most common type of hematological malignancy in the western world. CLL is characterized by a chronically relapsing course and clinical and biological heterogeneity. Many patients do not require any treatment for years. Although important progress has been made in the treatment of CLL, none of the conventional treatment options are curative. Recurrent chromosomal abnormalities have been identified and are associated with prognosis and pathogenesis of the disease. More recently, unbiased genome-wide technologies have identified multiple additional recurrent aberrations. The precise predictive value of these has not been established, but it is likely that the genetic heterogeneity observed at least partly reflects the clinical variability. The present article reviews our current knowledge of predictive markers in CLL using whole-genome technologies.
引用
收藏
页码:361 / 376
页数:16
相关论文
共 120 条
[1]   APPLICATIONS OF NEXT-GENERATION SEQUENCING Genome structural variation discovery and genotyping [J].
Alkan, Can ;
Coe, Bradley P. ;
Eichler, Evan E. .
NATURE REVIEWS GENETICS, 2011, 12 (05) :363-375
[2]   Next-generation DNA sequencing techniques [J].
Ansorge, Wilhelm J. .
NEW BIOTECHNOLOGY, 2009, 25 (04) :195-203
[3]   Exome sequencing as a tool for Mendelian disease gene discovery [J].
Bamshad, Michael J. ;
Ng, Sarah B. ;
Bigham, Abigail W. ;
Tabor, Holly K. ;
Emond, Mary J. ;
Nickerson, Deborah A. ;
Shendure, Jay .
NATURE REVIEWS GENETICS, 2011, 12 (11) :745-755
[4]   Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA [J].
Barrett, MT ;
Scheffer, A ;
Ben-Dor, A ;
Sampas, N ;
Lipson, D ;
Kincaid, R ;
Tsang, P ;
Curry, B ;
Baird, K ;
Meltzer, PS ;
Yakhini, Z ;
Bruhn, L ;
Laderman, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (51) :17765-17770
[5]   The landscape of somatic copy-number alteration across human cancers [J].
Beroukhim, Rameen ;
Mermel, Craig H. ;
Porter, Dale ;
Wei, Guo ;
Raychaudhuri, Soumya ;
Donovan, Jerry ;
Barretina, Jordi ;
Boehm, Jesse S. ;
Dobson, Jennifer ;
Urashima, Mitsuyoshi ;
Mc Henry, Kevin T. ;
Pinchback, Reid M. ;
Ligon, Azra H. ;
Cho, Yoon-Jae ;
Haery, Leila ;
Greulich, Heidi ;
Reich, Michael ;
Winckler, Wendy ;
Lawrence, Michael S. ;
Weir, Barbara A. ;
Tanaka, Kumiko E. ;
Chiang, Derek Y. ;
Bass, Adam J. ;
Loo, Alice ;
Hoffman, Carter ;
Prensner, John ;
Liefeld, Ted ;
Gao, Qing ;
Yecies, Derek ;
Signoretti, Sabina ;
Maher, Elizabeth ;
Kaye, Frederic J. ;
Sasaki, Hidefumi ;
Tepper, Joel E. ;
Fletcher, Jonathan A. ;
Tabernero, Josep ;
Baselga, Jose ;
Tsao, Ming-Sound ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Janne, Pasi A. ;
Daly, Mark J. ;
Nucera, Carmelo ;
Levine, Ross L. ;
Ebert, Benjamin L. ;
Gabriel, Stacey ;
Rustgi, Anil K. ;
Antonescu, Cristina R. ;
Ladanyi, Marc ;
Letai, Anthony .
NATURE, 2010, 463 (7283) :899-905
[6]   A genomic view of mosaicism and human disease [J].
Biesecker, Leslie G. ;
Spinner, Nancy B. .
NATURE REVIEWS GENETICS, 2013, 14 (05) :307-320
[7]   Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse [J].
Braggio, E. ;
Kay, N. E. ;
VanWier, S. ;
Tschumper, R. C. ;
Smoley, S. ;
Eckel-Passow, J. E. ;
Sassoon, T. ;
Barrett, M. ;
Van Dyke, D. L. ;
Byrd, J. C. ;
Jelinek, D. F. ;
Shanafelt, T. D. ;
Fonseca, R. .
LEUKEMIA, 2012, 26 (07) :1698-1701
[8]   Extending the scope of diagnostic chromosome analysis: Detection of single gene defects using high-resolution SNP microarrays [J].
Bruno, Damien L. ;
Stark, Zornitza ;
Amor, David J. ;
Burgess, Trent ;
Butler, Kathy ;
Corrie, Sylvea ;
Francis, David ;
Ganesamoorthy, Devika ;
Hills, Louise ;
James, Paul A. ;
O'Rielly, Darren ;
Oertel, Ralph ;
Savarirayan, Ravi ;
Prabhakara, Krishnamurthy ;
Salce, Nicholas ;
Slater, Howard R. .
HUMAN MUTATION, 2011, 32 (12) :1500-1506
[9]   Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial [J].
Catovsky, D. ;
Richards, S. ;
Matutes, E. ;
Oscier, D. ;
Dyer, M. J. S. ;
FBezares, R. ;
Pettitt, A. R. ;
Hamblin, T. ;
Milligan, D. W. ;
Child, J. A. ;
Hamilton, M. S. ;
Dearden, C. E. ;
Smith, A. G. ;
Bosanquet, A. G. ;
Davis, Z. ;
Brito-Babapulle, V. ;
Else, M. ;
Wade, R. ;
Hillmen, P. .
LANCET, 2007, 370 (9583) :230-239
[10]   Performance comparison of exome DNA sequencing technologies [J].
Clark, Michael J. ;
Chen, Rui ;
Lam, Hugo Y. K. ;
Karczewski, Konrad J. ;
Chen, Rong ;
Euskirchen, Ghia ;
Butte, Atul J. ;
Snyder, Michael .
NATURE BIOTECHNOLOGY, 2011, 29 (10) :908-U206